Pharma Innovation Programme Singapore (PIPS)
The Pharma Innovation Programme Singapore (PIPS) is an industry-led platform which aims to synergistically and strategically bring together public sector research capabilities and domain expertise of the pharmaceutical industry to enhance the productivity and operational efficiency within Singapore’s pharmaceutical sector through leveraging novel manufacturing technologies and data analytics.
Through this concerted effort spanning the public sector, industry partners, academia and government agencies, we will resolve pertinent issues to value-add to the sector and beyond. The current workstreams within PIPS include Biocatalysis, Continuous Manufacturing, Digital Factory, Particle Engineering and Plant Operations.
The consortium will continue to evolve according to the needs of the industry and align ourselves to be a focal point of excellence.
17 A*STAR researchers are recognised as the world's most influential scientific minds in 2022. Find out more about their work and what drives them to push the frontiers of scientific excellence!
A*STAR’s Highly Cited Researchers of 2022